Quick View
| Metric | Current Period | Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥1641.8B | ¥1581.2B | +3.8% |
| Operating Income | −¥10.0B | −¥11.9B | +16.3% |
| Profit Before Tax | ¥15.0B | ¥8.0B | +88.8% |
| Net Income | ¥13.1B | ¥94.6B | −86.2% |
| ROE | 0.2% | 1.6% | - |
Executive Summary
While the operating loss narrowed from the previous year and showed a trend toward improvement, quarterly net income attributable to owners of the parent declined substantially due to the reversal of a temporary tax-related increase in profit recorded in the previous year. Revenue was ¥1,641.8B (previous year ¥1,581.2B, YoY +3.8%), the operating loss was ¥9.97B (previous year loss of ¥11.91B, improving 16.3%), profit before tax was ¥15.0B (previous year ¥7.95B, YoY +88.8%), and quarterly net income attributable to owners of the parent was ¥12.9B (previous year ¥94.7B, YoY -86.4%). In the same period of the previous year, a special factor—recognition of ¥86.7B in income taxes and related items as income (including refunds)—boosted net income, and its reversal was the primary cause of the decline in profit this period. Revenue growth was driven by the Industry, Healthcare, Digital Manufacturing, and Precision Equipment businesses, while the Imaging Business, which had the largest composition ratio (44.4%), reported lower revenue.
Factors Affecting Results
【Revenue】Revenue was ¥1,641.8B, representing a year-on-year increase of +3.8%. By segment, four segments reported higher revenue: Industry +18.3%, Healthcare +19.9%, Digital Manufacturing +23.9%, and Precision Equipment +13.2%. Meanwhile, the Imaging Business, which had the largest composition ratio (44.4%), reported an 8.8% decline, weighing on the overall revenue growth rate.
【Profit and Loss】The gross profit margin was 39.3%, down 3.2pt from 42.5% in the previous year, primarily due to an increase in the cost-of-sales ratio (57.5%→60.7%). SG&A expenses were ¥668.3B, down ¥14.0B (-2.1%) year on year, confirming the effects of cost reductions; however, these savings were insufficient to offset the deterioration in the gross margin, and the operating loss remained at ¥9.97B. Nevertheless, the loss narrowed by ¥1.95B from the previous year’s ¥11.91B loss, representing a 16.3% improvement. Profit before tax increased to ¥15.02B (previous year ¥7.95B, +88.8%), but this was significantly supported by non-operating items, including financial income of ¥27.65B and share of profit of investments accounted for using the equity method of ¥9.65B. Quarterly net income attributable to owners of the parent was ¥12.89B, a decline of -86.4% from ¥94.69B in the previous year. This was largely attributable to the reversal of a temporary factor whereby income taxes and related items were recorded as income of ¥86.67B (negative tax expense) in the same period of the previous year. Income tax expense for the current period returned to a normal level of ¥1.96B (effective tax rate 13.0%). Overall, the results represent higher revenue and improved operating performance, but a substantial decline in net income due to the reversal of a special factor—i.e., higher revenue but lower net income.
Segment Analysis
The Imaging Business reported revenue of ¥729.7B (composition ratio 44.4%, YoY -8.8%) and operating income of ¥81.03B (YoY -27.5%, margin 11.1%), recording lower revenue and operating income but remaining the Company’s largest profit-contributing segment. The Precision Equipment Business reported revenue of ¥382.69B (composition ratio 23.3%, YoY +13.2%) but an operating loss of ¥26.32B (turning into a loss from operating income of ¥18.89B in the previous year, margin -6.9%). The Healthcare Business reported revenue of ¥277.91B (YoY +19.9%) and operating income of ¥10.53B (YoY +157.3%, margin 3.8%), with its profit surplus expanding. The Industry Business reported revenue of ¥179.26B (YoY +18.3%) and operating income of ¥30.07B (YoY +80.7%, margin 16.8%), maintaining the highest operating margin among all Company segments. The Digital Manufacturing Business reported revenue of ¥63.18B (YoY +23.9%) but remained substantially loss-making, with an operating loss of ¥21.97B (narrowing 47.6% from the previous year’s ¥21.97B loss, margin -34.8%). Company-wide, profits from the Imaging and Industry businesses offset losses in the Precision Equipment and Digital Manufacturing businesses, and the disparity in profitability among segments is weighing on the Company-wide margin.
Key Financial Indicators
【Profitability】The operating margin was -0.6% (an improvement of 0.2pt from -0.8% in the previous year), while the net profit margin was 0.8% (based on net income attributable to owners of the parent, down 5.2pt from 6.0% in the previous year). ROE was 0.2% (quarterly, non-annualized basis). 【Cash Quality】Operating cash flow was ¥205.3B, approximately 15.9 times net income attributable to owners of the parent of ¥12.89B, indicating that cash-generating capacity substantially exceeded the reported profit level. 【Investment Efficiency】The share of profit of investments accounted for using the equity method represented 64.2% of profit before tax, indicating a high degree of dependence on income other than core operating profit. 【Financial Soundness】The equity ratio was 54.1%, slightly down from 54.6% in the previous year but remaining at a high level. Current assets of ¥6,517.3B versus current liabilities of ¥3,419.9B resulted in a current ratio of 1.91x, a sound level.
Cash Flow Analysis
Operating cash flow was ¥205.3B, an increase of +366.4% from ¥44.0B in the previous year. The main contributing factors were an increase in advances received of +¥108.0B, an increase in trade payables and related items of +¥73.3B, and a decrease in trade receivables of +¥70.1B, while an increase in inventories of -¥38.5B partially offset these factors. Investing cash flow was -¥159.7B, primarily reflecting ¥97.2B in purchases of property, plant and equipment and ¥51.7B in purchases of intangible assets. Financing cash flow was -¥75.5B, mainly due to dividend payments of ¥48.7B and a net decrease in short-term borrowings of ¥5.5B. Free cash flow (operating cash flow + investing cash flow) was ¥45.5B, turning positive from -¥94.0B in the previous year (operating cash flow ¥44.0B + investing cash flow -¥138.0B). Cash and cash equivalents were ¥1,570.6B, down ¥9.8B from the end of the previous fiscal year, although a foreign currency translation adjustment of +¥20.3B provided support.
Quality of Earnings
The quality of earnings shows somewhat high dependence on non-recurring factors. Of profit before tax of ¥15.02B, operating profit and loss made a negative contribution of -¥9.97B, while financial income of ¥27.65B, financial expenses of -¥12.33B (net ¥15.32B), and share of profit of investments accounted for using the equity method of ¥9.65B supported the return to profitability. In particular, share of profit of investments accounted for using the equity method represented 64.2% of profit before tax, indicating that fluctuations in the performance of affiliated companies have a relatively significant impact on Company-wide profit. In the same period of the previous year, a temporary tax-related factor resulted in income taxes and related items of -¥86.67B (tax income). Accordingly, it should be noted that the year-on-year comparison of net income is substantially affected by special factors when compared with current-period income tax expense of ¥1.96B (effective tax rate 13.0%). From an accrual perspective, operating cash flow of ¥205.3B substantially exceeded net income attributable to owners of the parent of ¥12.89B, and the cash-generating capacity supporting earnings can be assessed as favorable.
Earnings Forecast and Guidance
Against the full-year Company forecast (revenue ¥7,320B, operating income ¥110B, net income attributable to owners of the parent ¥100B, EPS ¥30.36, and dividend ¥20), progress as of Q1 was 22.4% for revenue and 12.9% for net income (based on net income attributable to owners of the parent), both below the 25% benchmark for evenly distributed quarterly progress. Since the current period recorded an operating loss of ¥9.97B, a progress rate against the full-year forecast of ¥110B in operating income cannot be calculated. The Company revised its earnings forecast during the current quarter, and the booking of projects in the Precision Equipment Business and progress in improving profitability by segment during the second half are expected to be prerequisites for achieving the full-year forecast.
Shareholder Returns
The full-year dividend forecast is ¥20.00 per share, resulting in a payout ratio of 65.9% based on forecast EPS of ¥30.36. The Company recorded ¥48.72B in the current Q1 as payment of the previous fiscal year-end dividend. Compared with current-quarter net income attributable to owners of the parent of ¥12.89B, the simple quarterly payout ratio would be equivalent to 378%; however, this is a seasonal factor resulting from the timing gap between dividend payments and the recognition of quarterly profit, and it is appropriate to assess the payout ratio on a full-year basis at 65.9%. There was no revision to the dividend forecast during the current quarter, and given operating cash flow of ¥205.3B, sufficient cash resources for dividends have been secured.
Risk Factors
-
Segment profitability disparity: The Precision Equipment Business reported an operating loss of ¥26.32B (margin -6.9%), while the Digital Manufacturing Business reported an operating loss of ¥21.97B (margin -34.8%). Although the two segments together account for 27.2% of revenue composition, their combined operating loss reached ¥48.29B, creating a structure in which they absorb profits generated by the Imaging and Industry businesses.
-
Dependence on non-operating income: Of profit before tax of ¥15.02B, share of profit of investments accounted for using the equity method represented ¥9.65B (64.2%), while net financial income represented ¥15.32B, creating a structure that offsets operating loss (-¥9.97B). Changes in the performance of affiliated companies and in interest-rate and foreign-exchange trends have a relatively significant impact on profit before tax.
-
Inventory levels: Inventories were ¥3,383.0B, up +1.6% from the end of the previous fiscal year, and represented 339.6% of quarterly cost of sales (¥996.2B). Together with the 3.2pt decline in the gross profit margin (39.3%), inventory turnover and valuation trends require continued monitoring.
Industry Benchmark (Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | −0.6% | 8.7% (4.2%–14.2%) | −9.3pt |
| Net Profit Margin | 0.8% | 7.0% (3.2%–10.6%) | −6.2pt |
Both the operating margin and net profit margin are substantially below the industry median, placing the Company in the lower tier of the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (Year on Year) | 3.8% | 6.2% (-1.1%–14.6%) | −2.5pt |
The revenue growth rate is slightly below the industry median but remains within the IQR.
Source: Compiled by the Company
Key Points from the Financial Results
-
The operating loss narrowed by ¥1.95B year on year, representing a 16.3% improvement, but the gross profit margin declined by 3.2pt. Thus, profit improvement through SG&A expense reductions and an increase in the cost ratio are occurring simultaneously as contradictory trends.
-
Quarterly net income attributable to owners of the parent declined substantially by -86.4% year on year, primarily because income taxes and related items of ¥86.67B were recorded as temporary income in the same period of the previous year. On a profit-before-tax basis, however, profit increased by +88.8%, indicating an underlying improvement.
-
Progress against the full-year forecast was moderate, at 22.4% for revenue and 12.9% for net income, while operating income remained in the red at the quarterly stage. Profitability improvements in the Precision Equipment and Digital Manufacturing businesses during the second half will be key areas of focus for achieving the full-year forecast.
Theoretical Share Price (Reference Value)
This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade period). It is not a forecast of the market share price or a recommendation of any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥1,438 |
| base | ¥1,444 |
| bull | ¥1,452 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥1,801 |
| Adjusted Forecast EPS | ¥32.8 |
| Cost of Equity r | 9.27% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 0.50%) |
| Residual Income Persistence Factor ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 65.9% |
| Forecast EPS Confidence Adjustment | ×1.080 (based on the track record of guidance achievement in the same industry) |
| Implied PBR / PER | 0.80x / 44.0x |
Sensitivity: ¥1,405–¥1,485 at ±1% for the cost of equity, and ¥1,433–¥1,451 at ±0.1 for ω.
Notes:
- Since forecast ROE is below the cost of equity, the theoretical value is below book value per share.
- Net assets as of the quarterly end are used (there is a timing gap relative to the full-year forecast).
(Calculation model: Residual income model / Interest-rate reference month: 2026-07 / This value does not forecast or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmark is reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional advisor as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
Nikon’s FY2027 Q1 result was operationally weak despite modest revenue growth and a substantially stronger operating cash-flow outcome. Revenue rose 3.8% year on year to ¥164.2bn. Operating loss narrowed by ¥1.95bn to ¥1.0bn, improving the operating margin by 20bp to negative 0.6%. This improvement was insufficient to offset a 320bp deterioration in gross margin, which fell from 42.5% to 39.3%. Cost of sales increased 9.6%, materially faster than revenue growth, indicating adverse product mix, pricing, production-cost, or utilization pressure. SG&A declined 2.1% to ¥66.8bn, providing the principal offset to gross-profit compression. Segment-level profit declined from ¥8.5bn to ¥7.6bn, while unallocated corporate costs remained substantial at ¥8.6bn. The lower corporate-cost burden, including reduced growth-investment-related costs, was the main reason consolidated operating loss narrowed. Pretax profit nearly doubled to ¥1.5bn because finance income of ¥2.8bn and equity-method income of ¥1.0bn more than offset the operating loss and finance costs. However, net income attributable to owners fell 86.4% to ¥1.3bn, as the prior-year quarter benefited from a ¥8.7bn income-tax credit whereas the current quarter recorded a ¥0.2bn tax expense. Therefore, the sharp net-income decline primarily reflects a tax-base comparison effect rather than a comparable deterioration in pretax earnings. Cash generation was notably stronger: operating cash flow reached ¥20.5bn, versus ¥4.4bn a year earlier, and free cash flow was positive at ¥4.6bn after ¥14.9bn of tangible and intangible investment. Cash conversion was supported by lower receivables, increased payables, and higher customer advances, although inventories also increased. The balance sheet remains sound, with a 54.1% equity ratio, ¥157.1bn of cash, and a calculated current ratio of 1.91x. Still, inventory represented 30.8% of total assets and annualized inventory days were 310, creating a material working-capital and potential inventory-valuation risk. Full-year guidance implies a return to ¥11.0bn operating profit and ¥10.0bn profit attributable to owners, but Q1 revenue progress of 22.4% and the operating loss leave execution heavily weighted toward subsequent quarters. The key investment implication is that the company has liquidity and cash-flow capacity to fund its transformation investments, but sustainable rerating depends on restoring gross margin, converting Precision Equipment demand into profit, and reducing reliance on non-operating income.
Profitability Analysis
Annualized DuPont ROE is 0.9%, comprising a 0.8% net profit margin, 0.599x annualized asset turnover, and 1.84x financial leverage. The primary constraint is profitability rather than balance-sheet leverage: the net margin is well below the 3% concern threshold, while leverage is moderate. The 0.6% negative EBIT margin is the core issue, and the quality alert is valid because operating earnings do not cover finance costs on a conventional EBIT basis. Gross margin fell 320bp year on year to 39.3%, with cost of sales rising ¥8.7bn against only ¥6.1bn of revenue growth. SG&A fell ¥1.4bn year on year, equivalent to 210bp of revenue, partially cushioning the gross-margin decline. Other operating income improved by ¥0.6bn and other operating expenses declined by ¥0.9bn, also supporting the ¥2.0bn reduction in operating loss. The gross-profit deterioration nevertheless exceeded the benefit from lower SG&A and other operating items, leaving group EBIT negative. The five-factor DuPont interest burden is negative at negative 1.51x because pretax profit was generated outside EBIT; this is not evidence that cash interest alone consumed 251% of operating profit, but it does demonstrate that finance income and affiliate income were essential to remaining profitable before tax. Finance income of ¥2.8bn exceeded finance costs of ¥1.2bn, producing a net finance gain of ¥1.5bn. Equity-method income contributed ¥1.0bn, equal to 64.2% of pretax profit, confirming the flagged dependence on affiliate earnings. The effective tax rate was 13.0%, and the tax burden of 0.858x is normal in the current quarter; the year-on-year net-income decline instead reflects the non-recurring favorable tax comparison in FY2026 Q1. Operating leverage should improve if revenue growth is accompanied by a recovery in gross margin, as Q1 SG&A discipline was visible. However, the current margin structure is not sufficient to support the full-year profitability target without a significant sequential improvement.
Growth Assessment
Revenue growth of 3.8% was broad-based outside the Imaging business. Precision Equipment revenue increased 13.1% to ¥38.3bn, Healthcare increased 19.1% to ¥27.8bn, Industry increased 18.3% to ¥17.9bn, and Digital Manufacturing increased 23.9% to ¥6.3bn. Imaging, still the largest reported business by external revenue at ¥73.0bn, declined 8.8% year on year and remained the largest contributor to segment profit at ¥8.1bn. Imaging segment profit fell 27.5%, reducing its margin from 13.9% to 11.0%. Precision Equipment moved from a ¥1.9bn segment profit to a ¥2.6bn loss despite revenue growth, implying unfavorable mix, cost absorption, or timing effects in its equipment cycle. Healthcare turned profitable, improving from a ¥1.8bn loss to a ¥1.1bn profit, while Industry segment profit increased 80.7% to ¥3.0bn. Digital Manufacturing reduced its segment loss from ¥4.2bn to ¥2.2bn, but remains loss-making and continues to require investment. The core business remains Imaging because it has the largest operating-income contribution, although its revenue and margin decline make diversification and recovery in the other businesses strategically important. Reported segment profit totaled ¥7.6bn, but corporate and elimination costs of ¥8.6bn erased this profit at the consolidated operating level. Growth-investment-related expenses fell from ¥4.2bn to ¥3.1bn, which aided Q1 earnings but should be assessed alongside the need to build new growth platforms. Full-year revenue guidance is ¥732.0bn; Q1 progress is 22.4%, 2.6 percentage points below the standard 25% Q1 run rate. Full-year operating-profit guidance of ¥11.0bn requires a ¥12.0bn operating-profit swing from the Q1 loss, versus a standard Q1 progress expectation of ¥2.75bn. Profit attributable to owners progress is 12.9% of the ¥10.0bn forecast, also below the standard 25% run rate, though quarterly tax timing affects this comparison. Guidance was revised during the quarter, making the revised targets the relevant benchmark; delivery now requires recovery in the second half and/or a pronounced seasonal weighting. The low 2/10 consistency score reinforces that earnings progression has been volatile rather than reliably compounding.
Financial Health
Financial health is adequate, supported by ¥594.8bn of equity, a 54.1% equity ratio, and ¥157.1bn of cash and cash equivalents. Current assets of ¥651.7bn exceeded current liabilities of ¥342.0bn, producing a calculated current ratio of 1.91x; therefore there is no current-ratio warning. Calculated working capital is ¥309.7bn, providing a meaningful liquidity buffer. Short-term bonds and borrowings were ¥97.2bn, comfortably covered by cash alone at 1.62x and by current assets at 6.71x. Long-term bonds and borrowings were ¥122.3bn, so debt maturity is reasonably distributed between short- and long-term obligations rather than concentrated solely in near-term refinancing. Total interest-bearing borrowings were ¥219.4bn, equivalent to 36.9% of total equity. The reported debt-to-equity ratio of 0.84x remains below the 2.0x aggressive-leverage warning level, although its definition appears broader than interest-bearing borrowings. Negative EBIT means earnings-based interest coverage is weak, notwithstanding the positive net finance result generated by finance income. Finance costs were stable at ¥1.2bn, while interest paid in operating cash flow was ¥1.0bn, a manageable amount relative to quarterly operating cash flow. Total liabilities increased ¥15.6bn from fiscal year-end, driven primarily by ¥10.3bn growth in payables and ¥10.2bn growth in advances received. These movements improved operating cash flow but increase the importance of converting order-related customer advances into profitable delivery. Deferred tax assets of ¥73.3bn equal 12.3% of equity and remain a meaningful asset whose recoverability depends on future taxable profit generation. Other financial assets increased ¥7.3bn from fiscal year-end to ¥81.3bn, while total equity increased ¥6.6bn, largely through ¥10.2bn of OCI rather than retained earnings.
Notable B/S Changes
Property, plant and equipment: +¥61.5bn (+4.1% versus FY-end) - continued tangible investment increased the manufacturing asset base. Goodwill and intangible assets: +¥24.5bn (+2.6% versus FY-end) - intangible investment and portfolio valuation require ongoing assessment against future returns. Other noncurrent financial assets: +¥73.2bn (+9.9% versus FY-end) - increase contributed to noncurrent-asset growth and may add market-value sensitivity. Inventories: +¥54.2bn (+1.6% versus FY-end) - inventory increased despite already elevated 310 annualized DIO, heightening obsolescence and cash-conversion risk. Trade and other payables: +¥102.9bn (+14.0% versus FY-end) - supplier financing supported Q1 operating cash flow but may reverse. Advances received: +¥102.4bn (+15.2% versus FY-end) - reflects stronger customer prepayments/order conversion potential, with execution needed to realize revenue and margin. Other components of equity: +¥103.6bn (+9.5% versus FY-end) - mainly OCI gains, including ¥52.9bn fair-value gains on equity investments and ¥48.9bn foreign-currency translation gains; these gains strengthened book equity but are not operating earnings.
Cash Flow Quality
Cash-flow quality was strong in Q1 on a mechanical OCF-to-net-income basis: operating cash flow of ¥20.5bn was 15.92x net income of ¥1.3bn. This exceeds the 0.8x quality-warning threshold and is also consistent with the favorable negative 1.8% accruals ratio. The gap should not be interpreted as recurring cash earnings at the same multiple, because net income was unusually low following the reversal of the prior-year tax benefit and because working-capital inflows were important. Receivables declined by ¥7.0bn, payables increased by ¥7.3bn, and advances received increased by ¥10.8bn, collectively providing substantial cash support. Inventory increased by ¥3.8bn, consuming cash and taking quarter-end inventory to ¥338.3bn. The 310-day annualized DIO alert is material and must be monitored closely: it indicates a very long inventory holding period for a manufacturer and raises risks around demand forecasting, production scheduling, obsolescence, and eventual write-downs. High inventory is especially relevant for Nikon’s imaging, lithography, industrial-equipment, and digital-manufacturing product cycles, where product specifications and customer capital-spending plans can shift rapidly. Operating cash flow also benefited from depreciation and amortization of ¥10.5bn, well above quarterly EBIT, highlighting the gap between cash operating performance and accounting operating profit. Free cash flow was ¥4.6bn after ¥9.7bn of PPE capex and ¥5.2bn of intangible-asset purchases. This positive free cash flow is an improvement from the prior-year negative free cash flow position, when operating cash flow was only ¥4.4bn. However, FCF covered the ¥4.9bn cash dividend paid only narrowly, at approximately 0.93x. Investing outflow of ¥16.0bn exceeded tangible capex because of intangible investment and other investing outflows. Cash declined only ¥1.0bn in the quarter because operating cash flow funded investment, dividends, lease payments, and modest debt repayment. Cash-flow sustainability therefore depends on inventory discipline and whether advances received translate into delivery and margin, rather than becoming a source of working-capital reversal.
Dividend Sustainability
Dividend sustainability is supported by the company’s substantial equity base, net liquidity position, and positive Q1 free cash flow, but current-period cash coverage was tight. Q1 free cash flow of ¥4.6bn was slightly below dividends paid of ¥4.9bn. The cash shortfall was immaterial relative to ¥157.1bn of cash and ¥594.8bn of equity, but sustained dividends above free cash flow would reduce financial flexibility. The full-year dividend forecast is ¥20.00 per share, compared with forecast EPS of ¥30.36. This implies a forecast dividend payout ratio of approximately 65.9%, slightly above the stated 60% sustainability benchmark. No share buyback is identified in the period, so dividend payout ratio, rather than total return ratio, is the appropriate distribution metric. The forecast payout is feasible if the company achieves its ¥10.0bn full-year profit attributable-to-owners target and converts earnings into cash. However, Q1 profit attributable to owners was only ¥1.3bn and operating profit was negative, which means the dividend is currently supported more by balance-sheet capacity and expected future earnings than by Q1 earnings. Lower Q1 cash dividends paid versus the prior year also reduced the immediate funding burden. The principal dividend variables to monitor are recovery in operating margin, normalization of working capital, capex and intangible-investment requirements, and delivery against revised full-year guidance.
Risk Assessment
Business risks include High priority — Gross-margin pressure: gross margin fell 320bp to 39.3% despite revenue growth, indicating that mix, pricing, input costs, or factory utilization could prevent revenue growth from translating into earnings., High priority — Precision Equipment execution: revenue grew 13.1% but the segment shifted to a ¥2.6bn loss from a ¥1.9bn profit, exposing cyclicality and execution risk in semiconductor/FPD equipment demand, product mix, and utilization., High priority — Inventory risk: annualized DIO of 310 days is materially above the 90-day alert threshold. For a technology manufacturer, this elevates obsolescence, markdown, production-planning, and impairment risk if customer demand changes., Medium priority — Imaging normalization: the core Imaging business saw revenue decline 8.8% and segment margin fall 290bp to 11.0%, creating risk that cash-generative legacy products cannot fully fund growth investments., Medium priority — New-business profitability: Digital Manufacturing remained loss-making at ¥2.2bn despite 23.9% sales growth, requiring evidence that scale can offset continuing development and commercialization costs., Medium priority — FX and global-demand exposure: the group’s overseas operations, capital-equipment customers, and optical-product markets remain exposed to foreign-exchange movements, trade restrictions, and fluctuations in global industrial and consumer demand..
Financial risks include High priority — Low operating efficiency: EBIT margin was negative 0.6%, below the 5% concern benchmark, and annualized ROIC was negative 0.6%, below the 5% warning threshold. This signals inadequate current returns on the capital employed in the business., High priority — Earnings reliance on non-operating sources: equity-method income of ¥1.0bn represented 64.2% of pretax profit, while net finance income was ¥1.5bn. Affiliate and financial-market performance are less directly controllable than operating earnings., Medium priority — Interest-burden alert: the negative 1.51x EBIT-to-pretax relationship arises because EBIT is negative. Although cash interest is manageable and finance income exceeds finance costs, a sustained operating loss weakens conventional debt-service resilience., Medium priority — Working-capital reversal: Q1 operating cash flow was enhanced by increases in payables and advances received. Reversal without corresponding profit and shipment conversion would pressure future cash flow., Medium priority — Deferred-tax-asset reliance: deferred tax assets of ¥73.3bn are material and depend on the group’s ability to generate sufficient future taxable income..
Key concerns include The revised full-year operating-profit forecast requires a sharp improvement from the Q1 operating loss; quarterly revenue progress is also below a standard 25% first-quarter pace., Corporate costs of ¥8.6bn exceeded aggregate segment profit of ¥7.6bn, so segment recovery must be accompanied by continued discipline in headquarters and growth-investment spending., Other comprehensive income of ¥10.2bn, led by foreign-currency translation and equity-investment valuation gains, lifted equity but does not substitute for operating profitability or cash earnings., The company’s capital structure is not overstretched, but balance-sheet strength alone does not resolve the low-return profile indicated by negative EBIT and negative annualized ROIC..
Investment Implications
Key takeaways include Revenue growth and a narrower operating loss show partial stabilization, but the 320bp gross-margin decline means underlying operating recovery remains incomplete., Imaging remains the core profit contributor, while Healthcare and Industry improved meaningfully; Precision Equipment’s move into loss is the largest adverse segment development., Q1 cash flow was robust and free cash flow turned positive, but a significant portion of the improvement came from working-capital inflows and should be tested over subsequent quarters., Liquidity is strong, with a 1.91x current ratio, ¥157.1bn cash balance, and a 54.1% equity ratio., The revised full-year forecast requires substantial back-end profit delivery, making margin recovery, Precision Equipment profitability, and inventory normalization the central operational milestones., No investment recommendation is provided..
Metrics to watch include Gross margin and consolidated operating margin, particularly whether gross margin recovers from 39.3%., Precision Equipment segment margin and order/delivery conversion., Imaging revenue trend and segment margin relative to the current 11.0%., Inventory balance and annualized DIO relative to the current 310 days., Operating cash flow excluding changes in receivables, payables, and advances received., Corporate costs and growth-investment-related expenses relative to segment profit., Equity-method income and net finance income as proportions of pretax profit., Progress toward full-year revenue of ¥732.0bn, operating income of ¥11.0bn, net income attributable to owners of ¥10.0bn, and DPS of ¥20.00..
Regarding relative positioning, Nikon combines a resilient balance sheet and strong optical/equipment franchises with a currently sub-scale consolidated earnings profile. Relative to profitable global precision-equipment and technology-manufacturing peers, its negative operating margin and negative annualized ROIC are weak. Relative to more financially stressed cyclical manufacturers, its liquidity, equity ratio, and positive free cash flow provide meaningful downside resilience. Its competitive positioning will depend on whether higher-growth Healthcare, Industry, and Digital Manufacturing businesses can become durable profit contributors while the Imaging franchise retains cash-generative margins and Precision Equipment returns to profitability.